ABIVAX press release
Patrick Malloy is appointed Senior Vice President Investor Relations of Abivax.
Abivax today announces the appointment of Patrick Malloy as Senior Vice President Investor Relations. Mr. Malloy has 20 years of experience in investor relations and commercial leadership in the biopharmaceutical industry. He will play a decisive role in successfully advancing the international strategic positioning of Abivax and obefazimod with the investment community.